Dr. Peter B. Corr Joins Team at Celtic Therapeutics as Gener...(d decision-making very difficult.The inn...),Health

Date:12/18/2007

d decision-making very difficult. The innovative and timely Celtic model is designed to address these challenges. Celtic Therapeutics has assembled a first-class team of biomedical and financial industry leaders to bridge the gap between academia, biotechnology companies and the pharmaceutical industry. I am very pleased to be a part of this important project, which will help to bring a new range of therapies to patients."

Dr. Corr recently retired from Pfizer Inc, where he was Senior Vice President, Science and Technology, from 2002 to 2006, with responsibility for aligning Pfizer's worldwide research and development organization with licensing activities, science and medical advocacy, global medical relations and science policy. He previously headed Worldwide Research and Development, and prior to that served as Executive Vice President, Pfizer Global Research and Development, and as President, Worldwide Development. Prior to joining Pfizer, he served as President of Pharmaceutical Research and Development at Warner Lambert/Parke Davis until the merger with Pfizer in 2000, and served as Senior Vice President, Discovery Research, at Monsanto/Searle. He came to the private sector after spending 18 years as a researcher in molecular biology and pharmacology at Washington University in St. Louis, where he was a professor in the Departments of Medicine (Cardiology) and Pharmacology and Molecular Biology. Dr. Corr also serves on a number of for-profit and not-for-profit boards and councils.

In addition to his role at Celtic Therapeutics, Mr. Evans-Freke is the Co-Managing General Partner of Celtic Pharma, the predecessor private equity firm to Celtic Therapeutics. Both Mr. Evans-Freke and his co-founder in Celtic Pharma, John Mayo, will continue to serve as the Managing General Partners of Celtic Pharma's first fund, Celtic Pharmaceutical Holdings L.P., until its product development programs have been completed and sold and the partnership's affairs have b
'/>"/>

SOURCE Celtic Therapeutics Copyright©2007 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related medicine news :

1. St. Petersburg: Candlelight Vigil to Raise Awareness of Florida HIV/AIDS Crisis, Honor Lives Lost
2. Shameful Votes Today on Childrens Health Care by Reps. John Peterson, Joe Pitts and Bill Shuster
3. Mayo Clinics Dr. Ronald C. Petersen Awarded Leon Thal Prize for Excellence in Dementia Research
4. Richard Greco Joins Mediware Board
5. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
6. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
7. Dr. Mahesh Ramachandran Joins Marianjoy Medical Group
8. Nick Childs Joins Grey New York as Director of Content Development
9. Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book
10. David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager
11. NASN Joins Partnership to Fight Chronic Disease